- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- Genomic Health (Nasdaq: GHDX) hit a new 52-week high Monday as it is currently trading at $30.11, above its previous 52-week high of $30.09 with 283,851 shares traded as of 3:20 p.m. ET. Average volume has been 182,100 shares over the past 30 days. Genomic Health has a market cap of $785.7 million and is part of the health care sector and health services industry. Shares are up 16.9% year to date as of the close of trading on Friday. Genomic Health, Inc., a molecular diagnostics company, focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. The company has a P/E ratio of 113.9, below the average health services industry P/E ratio of 120.9 and above the S&P 500 P/E ratio of 17.7.